MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies

Melissa E Murray1, Tanis J Ferman, Bradley F Boeve

  • 1From the Department of Neuroscience (M.E.M., A.M.L., B.N.D., D.W.D.), Psychiatry and Psychology (T.J.F.), and Neurology (N.R.G.-R.), Mayo Clinic, Jacksonville, FL; and Department of Neurology (B.F.B., D.S.K., M.H.S., R.C.P.), Biomedical Statistics (S.A.P., T.G.L.), Radiology (M.L.S., J.L.G., G.M.P., P.V., C.R.J., K.K.), Nuclear Medicine (V.J.L.), Psychology (G.E.S.), Laboratory Medicine and Pathology (J.E.P.), and Center for Sleep Medicine (M.H.S.), Mayo Clinic, Rochester, MN.

Neurology
|October 11, 2013
PubMed
Abstract

Insights

REM sleep behavior disorder (pRBD) presence indicates higher dementia with Lewy bodies (DLB) likelihood and less Alzheimer-related pathology. Absence of pRBD suggests Alzheimer-like atrophy and increased tau burden.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Dementia with Lewy bodies (DLB) is a common neurodegenerative disorder.
  • REM sleep behavior disorder (pRBD) is a frequent non-motor symptom in DLB.
  • Understanding the neuropathological correlates of pRBD in DLB is crucial for diagnosis and prognosis.

Purpose of the Study:

  • To investigate the association between pRBD and neuropathological findings in individuals with varying likelihoods of DLB.
  • To compare neuroimaging (MRI) and digital microscopic characteristics in DLB patients with and without pRBD.

Main Methods:

  • Retrospective analysis of 75 autopsy-confirmed DLB cases stratified by likelihood (low, intermediate, high).
  • Assessment of antemortem clinical history for probable REM sleep behavior disorder (pRBD).
  • Voxel-based morphometry on MRI and measurement of phospho-tau, beta-amyloid, and alpha-synuclein burdens in the hippocampus and amygdala.

Main Results:

  • pRBD was present in 60% of high-likelihood DLB cases, decreasing with lower likelihoods.
  • Patients with pRBD showed younger age, male predominance, and diffuse Lewy body disease.
  • Lower phospho-tau and beta-amyloid burdens were observed in the hippocampus and amygdala in patients with pRBD; greater atrophy was seen in those without pRBD.

Conclusions:

  • The presence of pRBD is linked to a higher likelihood of DLB and reduced medial temporal lobe Alzheimer-related pathology.
  • Absence of pRBD in DLB is associated with MRI-evident atrophy patterns resembling Alzheimer's disease and increased medial temporal tau deposition.